Charles River Laboratories International (CRL) Invested Capital (2009 - 2022)

Charles River Laboratories International's Invested Capital history runs 14 years deep, the most recent figure standing at $2.1 million for Q3 2022.

• In Q3 2022, Invested Capital fell 8.62% year-over-year to $2.1 million; the TTM figure through Jul 2023 stood at $2.1 million (down 79.37% YoY), while the FY2021 annual figure was $2.8 million, down 94.43% from the prior year.
• Invested Capital for Q3 2022 stood at $2.1 million, down from $2.4 million in the prior quarter.
• The five-year high for Invested Capital was $53.7 million in Q2 2020, with the low at $2.1 million in Q3 2022.
• The 5-year median for Invested Capital is $30.6 million (2018), against an average of $23.8 million.
• The sharpest annual moves came in 2018 and 2020: Invested Capital plunged 97.39% in 2018, then soared 58.19% in 2020.
• Charles River Laboratories International's Invested Capital stood at $29.2 million in 2018, then soared by 31.82% to $38.5 million in 2019, then jumped by 30.27% to $50.2 million in 2020, then sank by 94.43% to $2.8 million in 2021, then fell by 25.62% to $2.1 million in 2022.
• Business Quant data shows CRL's Invested Capital at $2.1 million in Q3 2022, $2.4 million in Q2 2022, and $2.6 million in Q1 2022.